We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Astellas, Boehringer Sue Ranbaxy Over Flomax ANDA

Law360 (May 17, 2005, 12:00 AM EDT) -- Japanese drug maker Astellas Pharma Inc. has filed a patent infringement lawsuit against India’s Ranbaxy Laboratories over its plans to make a generic version of the prostate drug Flomax.

The lawsuit, filed in the U.S. District Court for the District of New Jersey, follows Ranbaxy Pharmaceuticals Inc.’s submission with the U.S. Food and Drug Administration of an abbreviated new drug application for a generic version of Astellas' drug product, sold under the trademark Flomax.

The complaint was filed jointly with Astellas marketing partner Boehringer Ingelheim Pharmaceuticals,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.